Methylprednisolone Before Fludeoxyglucose-Labeled Positron Emission Tomography in Patients With Lung Cancer

NCT01789892 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped no patient accrual

Conditions

Lung Cancer

Interventions

DRUG: methylprednisolone
RADIATION: fludeoxyglucose F 18
PROCEDURE: positron emission tomography
PROCEDURE: computed tomography

Sponsor

Ohio State University Comprehensive Cancer Center